Inotiv, Inc.

Inotiv, Inc. is a contract research organization that provides nonclinical and analytical drug discovery and development services. The company primarily serves the pharmaceutical and medical device industries, and also sells research-quality animals and diets to these industries, as well as to academia and government clients. Inotiv focuses on guiding new drugs and medical devices through the discovery and preclinical development phases, and sometimes through clinical development, with an emphasis on efficiency, data improvement, and cost reduction. Inotiv operates through two reportable segments: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The DSA segment offers discovery and translational sciences and safety assessment services, including nonclinical and, in some cases, clinical development. These services support researchers and clinicians working with small molecule drug candidates, biotherapeutics, and biomedical devices, utilizing both Good Laboratory Practice (GLP) and non-GLP standards. The company began operating in 1975 as Bioanalytical Systems, Inc., was incorporated in 1974, and completed an initial public offering in 2000. On March 18, 2021, the corporate name changed to Inotiv, Inc. Its stock is traded on The Nasdaq Stock Market LLC under the symbol "NOTV." Inotiv is headquartered in West Lafayette, Indiana, at 2701 Kent Avenue, West Lafayette, Indiana 47906, with a telephone number of (765) 463-4527.